Bridgeway Capital Management’s Live Oak Bancshares LOB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.3M Hold
154,378
0.11% 264
2026
Q1
$5.11M Sell
154,378
-22,024
-12% -$811K 0.1% 265
2025
Q4
$6.06M Buy
176,402
+35,000
+25% +$1.17M 0.13% 219
2025
Q3
$4.98M Buy
141,402
+20,286
+17% +$699K 0.11% 258
2025
Q2
$3.61M Sell
121,116
-69,566
-36% -$1.88M 0.09% 324
2025
Q1
$5.08M Buy
190,682
+90,931
+91% +$3.02M 0.13% 223
2024
Q4
$3.95M Hold
99,751
0.09% 332
2024
Q3
$4.73M Hold
99,751
0.1% 289
2024
Q2
$3.5M Buy
99,751
+2,000
+2% +$70.8K 0.08% 348
2024
Q1
$4.06M Buy
97,751
+6,500
+7% +$259K 0.08% 358
2023
Q4
$4.15M Buy
+91,251
New +$3.06M 0.09% 358
2020
Q2
Sell
-63,600
Closed -$793K 1355
2020
Q1
$793K Hold
63,600
0.02% 628
2019
Q4
$1.21M Hold
63,600
0.02% 696
2019
Q3
$1.15M Hold
63,600
0.02% 690
2019
Q2
$1.09M Hold
63,600
0.01% 709
2019
Q1
$929K Buy
63,600
+24,500
+63% +$377K 0.01% 784
2018
Q4
$579K Buy
+39,100
New +$754K 0.01% 948

Other funds holding LOB

Bridgeway Capital Management's LOB Position: Q2 2026 in Review

Bridgeway Capital Management held its Live Oak Bancshares (LOB) position steady in Q2 2026 at 154,378 shares worth $6.3M. The position accounts for 0.11% of the portfolio, ranked #264.

Bridgeway Capital Management first reported a position in LOB in Q4 2018 and has held it in 17 quarters since. 240 funds tracked by Wall St. Rank hold LOB as of Q2 2026.

  • Bridgeway Capital Management held 154,378 shares of Live Oak Bancshares worth $6.3M as of Q2 2026.
  • Bridgeway Capital Management left its Live Oak Bancshares share count unchanged in Q2 2026.
  • Live Oak Bancshares made up 0.11% of Bridgeway Capital Management's portfolio in Q2 2026, its #264 holding.
  • Bridgeway Capital Management first reported a position in Live Oak Bancshares in Q4 2018 and has held it in 17 quarters since.
  • 240 funds tracked by Wall St. Rank held Live Oak Bancshares as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.